|
05 Oct 2026
|
Molbio Diagnostics
|
Motilal Oswal
|
1544.70
|
1800.00
|
1503.40
(2.75%)
|
16.53 |
Buy
|
|
|
Molbio is a diagnostics technology company built around Truenat, its portable molecular testing platform that enables rapid point-of-care testing (POCT) with minimal infrastructure — bringing molecular diagnostics closer to the patient.
|
|
10 Aug 2026
|
Molbio Diagnostics
|
Deven Choksey
|
1544.70
|
|
|
|
IPO Subscribe
|
|
|
Molbio Diagnostics Ltd is a Goa-based point-of-care (POC) molecular diagnostics company built around its proprietary Truenat platform, a portable, battery-operated real-time PCR system capable of delivering molecular test results within one hour.
|